Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -8.90%565.34M | 10.80%1.28B | 28.74%620.58M | -4.89%1.15B | -20.48%482.03M | 13.74%1.21B | 5.11%606.19M | 11.84%1.06B | 22.55%576.72M | 1.98%951.25M |
| Operating income | -8.90%565.34M | 10.80%1.28B | 28.74%620.58M | -4.89%1.15B | -20.48%482.03M | 13.74%1.21B | 5.11%606.19M | 11.84%1.06B | 22.55%576.72M | 1.98%951.25M |
| Cost of sales | 7.13%-547.29M | -11.15%-1.21B | -30.71%-589.32M | 3.07%-1.09B | 20.38%-450.85M | -11.52%-1.13B | -4.79%-566.22M | -13.30%-1.01B | -22.97%-540.32M | -3.86%-890.72M |
| Operating expenses | 7.13%-547.29M | -11.15%-1.21B | -30.71%-589.32M | 3.07%-1.09B | 20.38%-450.85M | -11.52%-1.13B | -4.79%-566.22M | -13.30%-1.01B | -22.97%-540.32M | -3.86%-890.72M |
| Gross profit | -42.28%18.05M | 4.44%62.72M | 0.25%31.26M | -29.06%60.06M | -21.97%31.19M | 54.75%84.66M | 9.80%39.97M | -9.62%54.71M | 16.58%36.4M | -19.47%60.53M |
| Administrative expenses | 22.48%-11.99M | -2.38%-30.62M | -1.47%-15.47M | -29.80%-29.91M | -33.39%-15.25M | -6.95%-23.04M | -85.01%-11.43M | 10.72%-21.54M | -16.30%-6.18M | -7.09%-24.13M |
| Impairment and provision | -1,428.77%-2.82M | 16.20%-3.92M | 106.28%212K | -235.26%-4.68M | -1,083.67%-3.37M | 282.88%3.46M | 110.21%343K | 43.72%-1.89M | -1,477.93%-3.36M | -130.91%-3.36M |
| -Other impairment is provision | -1,428.77%-2.82M | 16.20%-3.92M | 106.28%212K | -235.26%-4.68M | -1,083.67%-3.37M | 282.88%3.46M | 110.21%343K | 43.72%-1.89M | -1,477.93%-3.36M | -130.91%-3.36M |
| Operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---12K | ---208K | ---- | ---- |
| Special items of operating profit | -40.77%2.42M | 1.76%8.96M | -8.02%4.08M | 254.00%8.8M | 700.00%4.44M | 120.45%2.49M | 250.00%555K | -278.60%-12.16M | -111.80%-370K | 138.54%6.81M |
| Operating profit | -71.84%5.66M | 8.36%37.14M | 18.13%20.09M | -49.27%34.27M | -42.20%17.01M | 257.47%67.57M | 11.07%29.42M | -52.57%18.9M | -8.13%26.49M | 18.93%39.85M |
| Financing cost | -342.86%-31K | 66.67%-9K | 53.33%-7K | -92.86%-27K | ---15K | ---14K | ---- | ---- | 15.71%-118K | 3.47%-195K |
| Share of profits of associates | ---- | 4.67%3.32M | 55.83%2.94M | 2,905.31%3.17M | --1.89M | ---113K | ---- | ---- | ---- | ---- |
| Earning before tax | -75.57%5.63M | 8.10%40.45M | 21.96%23.03M | -44.52%37.42M | -35.84%18.88M | 256.80%67.44M | 11.56%29.42M | -52.33%18.9M | -8.09%26.37M | 19.06%39.65M |
| Tax | 74.53%-795K | -0.71%-5.39M | -21.68%-3.12M | 50.19%-5.36M | 46.03%-2.57M | -92.72%-10.75M | -8.34%-4.75M | 0.04%-5.58M | 5.92%-4.39M | 36.62%-5.58M |
| After-tax profit from continuing operations | -75.73%4.83M | 9.34%35.05M | 22.01%19.9M | -43.44%32.06M | -33.87%16.31M | 325.51%56.69M | 12.21%24.67M | -60.90%13.32M | -8.51%21.99M | 39.08%34.07M |
| Earning after tax | -75.73%4.83M | 9.34%35.05M | 22.01%19.9M | -43.44%32.06M | -33.87%16.31M | 325.51%56.69M | 12.21%24.67M | -60.90%13.32M | -8.51%21.99M | 39.08%34.07M |
| Minority profit | -56.78%1.4M | -8.15%4M | 23.75%3.25M | 6,150.00%4.36M | --2.62M | ---72K | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | -79.42%3.43M | 12.08%31.05M | 21.67%16.66M | -51.19%27.7M | -44.50%13.69M | 326.05%56.76M | 12.21%24.67M | -60.90%13.32M | -8.51%21.99M | 39.08%34.07M |
| Basic earnings per share | -78.57%0.0012 | 12.08%0.0835 | -84.78%0.0056 | -51.18%0.0745 | -44.49%0.0368 | 326.26%0.1526 | 12.18%0.0663 | -60.92%0.0358 | -8.51%0.0591 | 39.00%0.0916 |
| Diluted earnings per share | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.